Searchable abstracts of presentations at key conferences in endocrinology

ea0014p547 | (1) | ECE2007

Effect of treatment with somatostatin analogue on glucose homeostasis in patients with acromegaly

Gavalas Nikos , Sabo Andrea , Papastathopoulou Lida , Botoula Efi , Tzanela Marinella

Long acting somatostatin analogues (SMS) are extensively used as second and even first line treatment of acromegaly. Except of the inhibition of GH secretion, somatostatin is a potent inhibitor of insulin secretion from the pancreatic b- cells. As defects of glucose homeostasis are very common in acromegaly, we decided to examine the effect of the control of GH hypersecretion with SMS on glucose metabolism.We study 44 acromegalic patients divided in 3 gr...

ea0032p896 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Effect of treatment outcome on co-morbidities of Cushing's disease

Assimakopoulou Athina , Tzanela Marinella , Palimeri Sotiria , Karapanou Olga , Botoula Efi , Tsagarakis Stylianos

Generously supported by IPSEN)-->Endogenous hypercortisolism leads to increased morbidity and mortality. As Cushing’s disease (CD) is a rare disorder, data on co-morbidities outcome after current treatment interventions are scarce.We studied 78 patients with CD (67 females, 11 males, mean age 42.2±1.4 years), with a follow up of 90.8±7.8 months. All patients underwent transsphenoidal surgery (TSS...